ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q3 2017. The put-call ratio across all filers is 4.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,451,000 | +33.7% | 20,052 | -2.5% | 0.02% | +40.0% |
| Q2 2021 | $2,581,000 | -5.1% | 20,565 | +2.6% | 0.02% | -16.7% |
| Q1 2021 | $2,719,000 | +1.4% | 20,049 | -4.3% | 0.02% | +5.9% |
| Q4 2020 | $2,682,000 | -14.2% | 20,960 | -24.5% | 0.02% | -26.1% |
| Q3 2020 | $3,126,000 | -2.4% | 27,775 | -17.4% | 0.02% | -8.0% |
| Q2 2020 | $3,202,000 | +31.8% | 33,611 | -48.3% | 0.02% | +316.7% |
| Q3 2017 | $2,429,000 | +20.2% | 65,051 | -2.1% | 0.01% | +20.0% |
| Q2 2017 | $2,020,000 | +11.9% | 66,474 | -2.5% | 0.01% | 0.0% |
| Q1 2017 | $1,805,000 | +6.5% | 68,182 | +2.7% | 0.01% | 0.0% |
| Q4 2016 | $1,695,000 | +59.9% | 66,406 | +89.5% | 0.01% | +66.7% |
| Q3 2014 | $1,060,000 | -16.9% | 35,038 | -6.7% | 0.00% | 0.0% |
| Q2 2014 | $1,276,000 | – | 37,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 2,803,645 | $84,782,000 | 78.57% |
| Cormorant Asset Management, LP | 400,000 | $12,096,000 | 2.49% |
| Deer VII & Co. Ltd. | 175,075 | $5,294,000 | 2.36% |
| QVT Financial LP | 1,193,258 | $36,084,000 | 1.86% |
| Foresite Capital Management I, LLC | 55,767 | $1,686,000 | 1.62% |
| Perceptive Advisors | 445,000 | $13,457,000 | 1.44% |
| SECTORAL ASSET MANAGEMENT INC | 726,424 | $21,967,000 | 0.92% |
| Iguana Healthcare Management, LLC | 25,000 | $756,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $3,024,000 | 0.37% |
| Eventide Asset Management | 62,100 | $1,878,000 | 0.26% |